Paper41009526
Investigating Germ Cell Transition Genes in Breast Cancer: Exploring the Genesis of Cancer Testis-Associated Markers.
Khodayari H and 10 others. Int J Mol Sci, 2025. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Investigating Germ Cell Transition Genes in Breast Cancer: Exploring the Genesis of Cancer Testis-Associated Markers. Papers, record 41009526. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41009526
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Investigating Germ Cell Transition Genes in Breast Cancer: Exploring the Genesis of Cancer Testis-Associated Markers.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Biomarkers, Tumor | Major topic |
| Germ Cells | Major topic |
| Testis | Major topic |
| Testicular Neoplasms | Major topic |
| Humans | |
| Male | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Gene Expression Profiling | |
| Single-Cell Analysis |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| no. 99-1-115-47842 | Cancer Research Center of Tehran University of Medical Science | PubMed |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34178612 | Germline Variants and Genetic Interactions of Several EMT Regulatory Genes Increase the Risk of HBV-Related Hepatocellular Carcinoma. | Front Oncol | 2021 | https://conductscience.org/library/papers/34178612 | PubMed |
| 2 | 35124721 | Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer. | Breast Cancer Res Treat | 2022 | https://conductscience.org/library/papers/35124721 | PubMed |
| 3 | 23396665 | Expression of Testis Specific Genes TSGA10, TEX101 and ODF3 in Breast Cancer. | Iran Red Crescent Med J | 2012 | https://conductscience.org/library/papers/23396665 | PubMed |
| 4 | 29326430 | EMT in cancer. | Nat Rev Cancer | 2018 | https://conductscience.org/library/papers/29326430 | PubMed |
| 5 | 24355749 | Deletion of MgcRacGAP in the male germ cells impairs spermatogenesis and causes male sterility in the mouse. | Dev Biol | 2014 | https://conductscience.org/library/papers/24355749 | PubMed |
| 6 | 30292353 | Emerging Contributions of Cancer/Testis Antigens to Neoplastic Behaviors. | Trends Cancer | 2018 | https://conductscience.org/library/papers/30292353 | PubMed |
| 7 | 29074977 | The Translation of Cyclin B1 and B2 is Differentially Regulated during Mouse Oocyte Reentry into the Meiotic Cell Cycle. | Sci Rep | 2017 | https://conductscience.org/library/papers/29074977 | PubMed |
| 8 | 36395590 | A multi-omics signature to predict the prognosis of invasive ductal carcinoma of the breast. | Comput Biol Med | 2022 | https://conductscience.org/library/papers/36395590 | PubMed |
| 9 | 34992437 | CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis. | Int J Gen Med | 2021 | https://conductscience.org/library/papers/34992437 | PubMed |
| 10 | 37666813 | Stromal cells in the tumor microenvironment: accomplices of tumor progression? | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37666813 | PubMed |
| 11 | 36270982 | A TNFR1-UBCH10 axis drives lung squamous cell carcinoma dedifferentiation and metastasis through a cell-autonomous signaling loop. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/36270982 | PubMed |
| 12 | 36076302 | The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/36076302 | PubMed |
| 13 | 16377660 | Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. | Hum Mol Genet | 2006 | https://conductscience.org/library/papers/16377660 | PubMed |
| 14 | 33173433 | Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients. | Int J Med Sci | 2020 | https://conductscience.org/library/papers/33173433 | PubMed |
| 15 | 35192545 | Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35192545 | PubMed |
| 16 | 24615626 | Clinical significance of RacGAP1 expression at the invasive front of gastric cancer. | Gastric Cancer | 2015 | https://conductscience.org/library/papers/24615626 | PubMed |
| 17 | 21205669 | Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila. | Science | 2010 | https://conductscience.org/library/papers/21205669 | PubMed |
| 18 | 36928776 | UBE2T resolves transcription-replication conflicts and protects common fragile sites in primordial germ cells. | Cell Mol Life Sci | 2023 | https://conductscience.org/library/papers/36928776 | PubMed |
| 19 | 20460541 | Pathways of proliferation and antiapoptosis driven in breast cancer stem cells by stem cell protein piwil2. | Cancer Res | 2010 | https://conductscience.org/library/papers/20460541 | PubMed |
| 20 | 29596365 | UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1. | Genes (Basel) | 2018 | https://conductscience.org/library/papers/29596365 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42666385 | MicroRNA cluster 7/17/155 as a potential driver for high-grade breast tumors transformation through EGFR-associated EMT. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42666385 | PubMed |
| 42653087 | Special Issue "Molecular Research and Cellular Biology of Breast Cancer". | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653087 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCNB1 | 891 | PubTator's text mining | https://conductscience.org/library/genes/891 | NCBI Gene |
| CCNB2 | 9133 | PubTator's text mining | https://conductscience.org/library/genes/9133 | NCBI Gene |
| PTTG1 | 9232 | PubTator's text mining | https://conductscience.org/library/genes/9232 | NCBI Gene |
| RACGAP1 | 29127 | PubTator's text mining | https://conductscience.org/library/genes/29127 | NCBI Gene |
| UBE2C | 11065 | PubTator's text mining | https://conductscience.org/library/genes/11065 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41009526
GET https://conductscience.org/api/papers/v1/41009526/references?page=2